切换至 "中华医学电子期刊资源库"

中华胃食管反流病电子杂志 ›› 2021, Vol. 08 ›› Issue (02) : 55 -60. doi: 10.3877/cma.j.issn.2095-8765.2021.02.002

论著

p38 丝裂原活化蛋白激酶、上皮细胞间质转化在胃食管反流病及食管腺癌组织中的表达及其临床意义
钟江利1, 王红1,(), 赵凌苇1   
  1. 1. 563000 贵州,遵义医科大学附属医院消化内科
  • 收稿日期:2020-12-16 出版日期:2021-05-15
  • 通信作者: 王红

Expression and clinical significance of p38 MAPK、EMT in Gastroesophageal reflux disease and adenocarcinoma tissue

Jiangli Zhong1, Hong Wang1,(), Lingwei Zhao1   

  1. 1. Department of Gastroenterology, Affiliated Hospital of Zunyi Medical University, Guizhou 563000, China
  • Received:2020-12-16 Published:2021-05-15
  • Corresponding author: Hong Wang
引用本文:

钟江利, 王红, 赵凌苇. p38 丝裂原活化蛋白激酶、上皮细胞间质转化在胃食管反流病及食管腺癌组织中的表达及其临床意义[J/OL]. 中华胃食管反流病电子杂志, 2021, 08(02): 55-60.

Jiangli Zhong, Hong Wang, Lingwei Zhao. Expression and clinical significance of p38 MAPK、EMT in Gastroesophageal reflux disease and adenocarcinoma tissue[J/OL]. Chinese Journal of Gastroesophageal Reflux Disease(Electronic Edition), 2021, 08(02): 55-60.

目的

探讨p38丝裂原活化蛋白激酶(MAPK)、E-cadherin、Vimentin蛋白在胃食管反流病及食管腺癌组织中的表达及其意义。

方法

收集2017年1月至2019年4月遵义医科大学附属医院病理科42例胃食管反流病患者蜡块标本(来源于消化内科内镜活检患者)为胃食管反流病组、2013年1月至2019年4月9例食管腺癌患者标本(来源于胸外科行食管腺癌切除术患者)为食管腺癌组、9例食管腺癌癌旁组织标本(来源于食管腺癌患者癌旁黏膜组织)为癌旁组。运用免疫组化法检测p38 MAPK、E-cadherin、Vimentin在3组患者中的表达情况,分析上述指标与胃食管反流病、食管腺癌的关系。

结果

在正常食管组织、胃食管反流病、食管腺癌组织中,p38 MAPK、Vimentin蛋白的表达呈逐渐上升趋势,E-cadherin蛋白的表达呈下降趋势。

结论

p38 MAPK、Vimentin、E-cadherin的异常表达可能参与了胃食管反流病及食管腺癌的发病。

Objective

To explore the Expression and significance of p38 mitogen-activated protein kinase(MAPK)、E-cadherin, Vimentin protein in gastroesophageal reflux disease and esophageal adenocarcinoma tissues.

Methods

Collect from January 2017 to April 2019 Wax block specimens from 42 patients(undergoing endoscopic biopsy in Gastroenterology) in Pathology Department of Zunyi Medical University were gastroesophageal reflux disease group, 9 patients with esophageal adenocarcinoma (undergoing esophageal adenocarcinoma resection) from January 2013 to April 2019 were esophageal adenocarcinoma group, nine esophageal adenocarcinoma adjacent tissue specimens (derived from the adjacent mucosal tissue of esophageal adenocarcinoma patients) were the paracancerous group. Immunohistochemical method was used to detect the expression of p38 MAPK, E-cadherin, and Vimentin in the three groups of patients, and the relationship between the above indicators and gastroesophageal reflux disease and esophageal adenocarcinoma was analyzed.

Results

In paracancerous tissues of esophageal adenocarcinoma, gastroesophageal reflux disease tissues, esophageal adenocarcinoma tissues, p38 MAPK and Vimentin are expressed in a gradually increasing trend, while E-cadherin is expressed in a gradually decreasing trend.

Conclusion

The abnormal expression of p38 MAPK、E-cadherin, Vimentin may be involved in the pathogenesis of gastroesophageal reflux disease and esophageal adenocarcinoma.

图1 -p38 MAPK在3组中的表达(×400)
表1 p38 MAPK、E-cadherin、Vimentin在食管腺癌癌旁组织、胃食管反流病组织、食管腺癌组织中的阳性率(%)
图2 -E-cadherin在3组中的表达(×400)
图3 -E-Vimentin在3组中的表达(×400)
表2 p38 MAPK、E-cadherin、Vimentin在胃食管反流病的表达与临床特征之间的关系
1
Clarrett DM, Hachem C. Gastroesophageal Reflux Disease (GERD)- [J]. Mo Med, 2018, 115(3): 214-218.
2
周金池, 窦维佳, 魏延, 等.中国胃食管反流病患者焦虑抑郁患病率的Meta分析 [J].中国全科医学, 2021, 24(5):608-613.
3
Hill RJ, Dabbagh K, Phippard D, et al. Pamapimod, a novel p38 mitogen-activated protein kinase inhibitor: preclinical analysis of efficacy and selectivity [J]. J Pharmacol Exp Ther, 2008, 327(3): 610-619.
4
Shan J, Oshima T, Wu L, et al. Interferon γ-Induced Nuclear Interleukin-33 Potentiates the Release of Esophageal Epithelial Derived Cytokines [J]. PLoS One, 2016, 11(3): e0151701.
5
Liu G, Jiang C, Li D, et al. Isorhamnetin alleviates esophageal mucosal injury in a chronic model of reflux esophagitis [J], Eur J Pharmacol, 2019, 864:172720.
6
李航宇, 李岩, 刘丹, 等. LPS通过p38/MAPK调控胆管癌细胞系ICBD的上皮间质转化 [J]. 世界华人消化杂志, 2013, 21(21): 2070-2075.
7
黄懋敏, 董丹丹, 亓丹丹, 等. 慢性萎缩性胃炎患者Hp感染与TGF-βRⅡ、IL-6和TNF-α的表达研究 [J]. 中国免疫学杂志, 2018, 34(5): 751-756.
8
Singh RK, Diwan M, Dastidar SG, et al. Differential effect of p38 and MK2 kinase inhibitors on the inflammatory and toxicity biomarkers in vitro [J]. Hum Exp Toxicol, 2018, 37(5): 521-531.
9
Pettus LH, Wurz RP. Small molecule p38 MAP kinase inhibitors for the treatment of inflammatory diseases: novel structures and developments during 2006-2008 [J]. Curr Top Med Chem, 2008, 8(16): 1452-1467.
10
Capaldo CT, Farkas AE, Hilgarth RS, et al. Proinflammatory cytokine-induced tight junction remodeling through dynamic self-assembly of claudins [J]. Mol Biol Cell. 2014, 25(18): 2710-2719.
11
柳刚. p38MAPK在GERD发生发展过程中的作用和机制研究 [D]. 第二军医大学, 2015:1-103
12
Zhang L, Liu G, Han X, et al. Inhibition of p38 MAPK activation attenuates esophageal mucosal damage in a chronic model of reflux esophagitis [J]. Neurogastroenterol Motil. 2015, 27(11): 1648-1656.
13
Chang JT, Katzka DA. Gastroesophageal reflux disease, Barrett esophagus, and esophageal adenocarcinoma [J]. Arch Intern Med, 2004, 164(14): 1482-1488.
14
Dvorak K, Goldman A, Kong J, et al. Molecular mechanisms of Barrett's esophagus and adenocarcinoma [J]. Ann N Y Acad Sci, 2011,1232: 381-391.
15
Hong J, Behar J, Wands J, et al. Bile acid reflux contributes to development of esophageal adenocarcinoma via activation of phosphatidylinositol-specific phospholipase Cgamma2 and NADPH oxidase NOX5-S [J]. Cancer Res, 2010, 70(3): 1247-1255.
16
Chwiesko A, Baniukiewicz A, Semeniuk J, et al. Activity of mitogen-activated protein kinases in the esophageal epithelium of patients with Barrett's esophagus [J]. Dis Esophagus, 2015, 28(6): 585-592.
17
Zhang HY, Zhang X, Chen X, et al. Differences in activity and phosphorylation of MAPK enzymes in esophageal squamous cells of GERD patients with and without Barrett's esophagus [J]. Am J Physiol Gastrointest Liver Physiol, 2008, 295(3): G470-478.
18
徐亭亭, 崔金刚, 朱生樑, 等. 食管纤维化与食管腺癌发病分子机制的研究进展 [J]. 生理科学进展, 2018, 49(6):475-477.
19
Kandulski A, Malfertheiner P. Gastroesophageal reflux disease--from reflux episodes to mucosal inflammation [J]. Nat Rev Gastroenterol Hepatol, 2011, 9(1): 15-22.
20
Gargus M, Niu C, Vallone JG, et al. Human esophageal myofibroblasts secrete proinflammatory cytokines in response to acid and Toll-like receptor 4 ligands [J]. Am J Physiol Gastrointest Liver Physiol, 2015,308(11): G904-923.
21
朱梅, 张腾, 李黎. 胆汁致消化道黏膜损伤机制的研究进展 [J]. 生理科学进展, 2020, 51(3):203-206.
22
Zhang Q, Agoston AT, Pham TH, et al. Acidic Bile Salts Induce Epithelial to Mesenchymal Transition via VEGF Signaling in Non-Neoplastic Barrett's Cells [J]. Gastroenterology, 2019, 156(1): 130-144.e10.
23
Zhang Y, Wang LF, Gao JH, et al. Clinical significance of epithelial-mesenchymal transition-related molecules in lung adenocarcinoma [J]. Curr Oncol, 2019, 26(2): e121-e127.
24
Shi J, Chen J, Serradji N, et al. PMS1077 sensitizes TNF-α induced apoptosis in human prostate cancer cells by blocking NF-κB signaling pathway [J]. PLoS One, 2013, 8(4): e61132.
25
Sun X, Zhang J, Wang Z, et al. Shp2 Plays a Critical Role in IL-6-Induced EMT in Breast Cancer Cells [J]. Int J Mol Sci, 2017, 18(2):395.
[1] 邢益民, 张天飞, 戴慧勇. 胃肠充盈超声造影检查在反酸、嗳气患者临床诊断中的应用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(03): 303-306.
[2] 李海云, 赵敏娴, 申英末, 杨慧琪. 胃底折叠术预防食管裂孔疝术后并发症的研究进展[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(05): 485-490.
[3] 玉素江·图荪托合提, 韩琦, 麦麦提艾力·麦麦提明, 黄旭东, 王浩, 克力木·阿不都热依木, 艾克拜尔·艾力. 腹腔镜袖状胃切除或联合食管裂孔疝修补术对肥胖症合并胃食管反流病的中期疗效分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(05): 501-506.
[4] 任传富, 杨志, 徐恩, 何梓芸, 罗板鑫, 陈新, 夏雪峰. 腹腔镜疝修补术联合胃底折叠术治疗食管裂孔疝合并胃食管反流病40 例临床分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(05): 507-511.
[5] 胡志伟, 吴继敏, 汪忠镐, 张美光. 胃食管反流病食管外症状抗反流手术适应证及术前评估[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(03): 241-246.
[6] 胡志伟, 吴继敏, 邓昌荣, 战秀岚, 纪涛, 王峰, 田书瑞, 陈冬, 张玉, 刘健男, 宋庆. 抗反流黏膜套扎治疗顽固性胃食管反流病[J/OL]. 中华腔镜外科杂志(电子版), 2024, 17(04): 227-233.
[7] 孙武青, 郭震, 郝少龙, 孙海涛, 姬阆, 白日星, 韩威. LSG中保留胃窦部及His角完整性对术后胃食管反流病的影响[J/OL]. 中华腔镜外科杂志(电子版), 2024, 17(02): 95-99.
[8] 唐小久, 胡曼, 许必君, 肖亚. 肥胖合并胃食管反流病患者严重程度与其焦虑抑郁及营养状态的相关性研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(04): 360-364.
[9] 张静, 白亦冰, 来要良, 刘永, 和媛媛, 苏敏. 不同体位对胃食管反流病患者食管高分辨率测压的影响[J/OL]. 中华胃食管反流病电子杂志, 2024, 11(03): 115-120.
[10] 张靖, 柏君, 陈玉盟, 张鹏, 侯芳芳, 王军芳, 孙静, 赵士博, 杨喆, 张玥, 张瑞芳, 朱宏斌. 抗反流黏膜消融术治疗胃食管反流病患者的临床疗效[J/OL]. 中华胃食管反流病电子杂志, 2024, 11(03): 121-125.
[11] 华丽, 仲卫冬, 胡根, 张丽英, 邵国益. 手术治疗胃食管反流病对患者生活质量和心理状态影响的研究[J/OL]. 中华胃食管反流病电子杂志, 2024, 11(03): 126-129.
[12] 文明, 张丽, 谢芳, 艾克拜尔·艾力, 克力木·阿不都热依木. 构建胃食管反流病患者发生心房颤动的临床预测模型[J/OL]. 中华胃食管反流病电子杂志, 2024, 11(03): 130-136.
[13] 高训锋, 许晓露, 张金辉, 蔡理全, 张恒, 邰沁文. 胃食管反流病与肝胆胰系统疾病的因果关系:一项孟德尔随机化研究[J/OL]. 中华胃食管反流病电子杂志, 2024, 11(03): 143-152.
[14] 刘虎, 任振, 韦笑韩, 潘晨, 吴立胜. 胃食管反流伴食管运动障碍的诊疗进展[J/OL]. 中华胃食管反流病电子杂志, 2024, 11(03): 153-158.
[15] 中国医师协会外科医师分会肥胖和代谢病外科专家工作组, 中国医师协会外科医师分会胃食管反流疾病诊疗外科专家工作组, 日本肥胖治疗学会, 韩国减重与代谢外科学会. 袖状胃切除术患者胃食管反流病诊治专家共识(2024版)[J/OL]. 中华肥胖与代谢病电子杂志, 2024, 10(03): 145-162.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?